EAM
Exane Asset Management Portfolio holdings
AUM
$256M
1-Year Return
8.08%
This Quarter Return
-6.27%
1 Year Return
+8.08%
3 Year Return
+70.48%
5 Year Return
+81.39%
10 Year Return
–
AUM
$170M
AUM Growth
-$149M
(-47%)
Cap. Flow
-$123M
Cap. Flow
% of AUM
-72.33%
Top 10 Holdings %
Top 10 Hldgs %
68.38%
Holding
199
New
70
Increased
19
Reduced
16
Closed
92
Top Buys
| 1 |
Takeda Pharmaceutical
TAK
|
$15.7M |
| 2 |
T-Mobile US
TMUS
|
$11.4M |
| 3 |
AT&T
T
|
$11.1M |
| 4 |
Sherwin-Williams
SHW
|
$7.05M |
| 5 |
RHT
Red Hat Inc
RHT
|
$5.27M |
Top Sells
| 1 |
Qiagen
QGEN
|
$19.7M |
| 2 |
Bristol-Myers Squibb
BMY
|
$13.9M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$12M |
| 4 |
UBS Group
UBS
|
$11M |
| 5 |
Gilead Sciences
GILD
|
$10.2M |
Sector Composition
| 1 | Materials | 31.17% |
| 2 | Communication Services | 24.88% |
| 3 | Healthcare | 19.33% |
| 4 | Utilities | 7.37% |
| 5 | Technology | 6.65% |
